Exact Mass: 734.3911

Exact Mass Matches: 734.3911

Found 189 metabolites which its exact mass value is equals to given mass value 734.3911, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PA(14:0/6 keto-PGF1alpha)

[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-(tetradecanoyloxy)propoxy]phosphonic acid

C37H67O12P (734.437)


PA(14:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/6 keto-PGF1alpha), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(6 keto-PGF1alpha/14:0)

[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-(tetradecanoyloxy)propoxy]phosphonic acid

C37H67O12P (734.437)


PA(6 keto-PGF1alpha/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/14:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(14:0/TXB2)

[(2R)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-(tetradecanoyloxy)propoxy]phosphonic acid

C37H67O12P (734.437)


PA(14:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/TXB2), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(TXB2/14:0)

[(2R)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-(tetradecanoyloxy)propoxy]phosphonic acid

C37H67O12P (734.437)


PA(TXB2/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/14:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-14:0/6 keto-PGF1alpha)

[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C37H67O12P (734.437)


PA(i-14:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/6 keto-PGF1alpha), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(6 keto-PGF1alpha/i-14:0)

[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C37H67O12P (734.437)


PA(6 keto-PGF1alpha/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/i-14:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-14:0/TXB2)

[(2R)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C37H67O12P (734.437)


PA(i-14:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/TXB2), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(TXB2/i-14:0)

[(2R)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C37H67O12P (734.437)


PA(TXB2/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/i-14:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Colocynthoside A

Colocynthoside A

C38H54O14 (734.3513)


   

Bafilomycin C2

Bafilomycin C2

C40H62O12 (734.4241)


   

Hoodigoside A

Hoodigoside A

C40H62O12 (734.4241)


   

Prieurianoside

Prieurianoside

C40H62O12 (734.4241)


   

Sublanceoside C1

Cynajapogenin A 3-O-alpha-L-cymaropyranosyl-(1-

C39H58O13 (734.3877)


   
   
   
   

eremophiloside G

eremophiloside G

C40H62O12 (734.4241)


   

6-O-capryl-3-O-isobutyryl-3,4-di-O-(2-methylbutyryl)sucrose

6-O-capryl-3-O-isobutyryl-3,4-di-O-(2-methylbutyryl)sucrose

C36H62O15 (734.4089)


   

3-O-beta-D-xylopyranosyl-(1->2)-alpha-L-arabinopyranosyl gypsogenin

3-O-beta-D-xylopyranosyl-(1->2)-alpha-L-arabinopyranosyl gypsogenin

C40H62O12 (734.4241)


   

bistabercarpamines A

bistabercarpamines A

C44H54N4O6 (734.4043)


   

Hebelomic acid F

Hebelomic acid F

C40H62O12 (734.4241)


   
   

16-decarbomethoxyvoacamine

16-decarbomethoxyvoacamine

C44H54N4O6 (734.4043)


   
   

(3R)-tabernaelegantinal B

(3R)-tabernaelegantinal B

C44H54N4O6 (734.4043)


   

(3R)-tabernaelegantinal A

(3R)-tabernaelegantinal A

C44H54N4O6 (734.4043)


   
   

3-beta-[(beta-D-glucopyranosyl-(1->2)-O-alpha-L-arabinopyranosyl)oxy]-30-norolean-12-en-28-oic acid

3-beta-[(beta-D-glucopyranosyl-(1->2)-O-alpha-L-arabinopyranosyl)oxy]-30-norolean-12-en-28-oic acid

C40H62O12 (734.4241)


   
   

3,21-diacetyl-2-(3-hydroxy-3-methyl)glutarylcrustulinol

3,21-diacetyl-2-(3-hydroxy-3-methyl)glutarylcrustulinol

C40H62O12 (734.4241)


   

DHPNPR|H-Asp-His-Pro-Asn-Pro-Arg-OH

DHPNPR|H-Asp-His-Pro-Asn-Pro-Arg-OH

C30H46N12O10 (734.346)


   

2-acetyl-3-dodecanoyl-3-(2-methylbutanoyl)-4-(3-methylbutanoyl)sucrose

2-acetyl-3-dodecanoyl-3-(2-methylbutanoyl)-4-(3-methylbutanoyl)sucrose

C36H62O15 (734.4089)


   

2-acetyl-3-dodecanoyl-3,4-di(3-methylbutanoyl)sucrose

2-acetyl-3-dodecanoyl-3,4-di(3-methylbutanoyl)sucrose

C36H62O15 (734.4089)


   

Desoxycabufiline

Desoxycabufiline

C44H54N4O6 (734.4043)


   

LPIM1 16:0

2-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C31H59O17P (734.349)


   

OKDdiA-PG

1-(9Z-octadecenoyl)-2-(9-oxo-11-carboxy-10E-undecenoyl)-sn-glycero-3-phospho-(1-sn-glycerol)

C36H63O13P (734.4006)


   

L-Phenylalanine, N,N-(((2-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis-, bis(2-methylpropyl) ester

L-Phenylalanine, N,N-(((2-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis-, bis(2-methylpropyl) ester

C37H51N8O6P (734.3669)


   

Acylsucrose S4:24[6] (2,5,5,12)

Acylsucrose S4:24[6] (2,5,5,12)

C36H62O15 (734.4089)


   

2-Acetyl-3-lauryl-3,4-di(isovaleryl)sucrose

2-Acetyl-3-lauryl-3,4-di(isovaleryl)sucrose

C36H62O15 (734.4089)


   

PA(i-14:0/TXB2)

PA(i-14:0/TXB2)

C37H67O12P (734.437)


   

PA(TXB2/i-14:0)

PA(TXB2/i-14:0)

C37H67O12P (734.437)


   

PA(14:0/6 keto-PGF1alpha)

PA(14:0/6 keto-PGF1alpha)

C37H67O12P (734.437)


   

PA(6 keto-PGF1alpha/14:0)

PA(6 keto-PGF1alpha/14:0)

C37H67O12P (734.437)


   

PA(14:0/TXB2)

PA(14:0/TXB2)

C37H67O12P (734.437)


   

PA(TXB2/14:0)

PA(TXB2/14:0)

C37H67O12P (734.437)


   

PA(i-14:0/6 keto-PGF1alpha)

PA(i-14:0/6 keto-PGF1alpha)

C37H67O12P (734.437)


   

PA(6 keto-PGF1alpha/i-14:0)

PA(6 keto-PGF1alpha/i-14:0)

C37H67O12P (734.437)


   

1-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

1-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C41H49F3N4O5 (734.3655)


   

1-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

1-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C41H49F3N4O5 (734.3655)


   

1-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

1-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C41H49F3N4O5 (734.3655)


   

1-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

1-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C41H49F3N4O5 (734.3655)


   

1-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

1-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C41H49F3N4O5 (734.3655)


   

1-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

1-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(1-naphthalenyl)urea

C41H49F3N4O5 (734.3655)


   

Smgdg O-8:0_20:3

Smgdg O-8:0_20:3

C37H66O12S (734.4275)


   

Smgdg O-20:3_8:0

Smgdg O-20:3_8:0

C37H66O12S (734.4275)


   

Smgdg O-26:3_2:0

Smgdg O-26:3_2:0

C37H66O12S (734.4275)


   

Smgdg O-22:3_6:0

Smgdg O-22:3_6:0

C37H66O12S (734.4275)


   

Smgdg O-24:3_4:0

Smgdg O-24:3_4:0

C37H66O12S (734.4275)


   

Smgdg O-12:0_16:3

Smgdg O-12:0_16:3

C37H66O12S (734.4275)


   

Smgdg O-10:0_18:3

Smgdg O-10:0_18:3

C37H66O12S (734.4275)


   

Smgdg O-16:3_12:0

Smgdg O-16:3_12:0

C37H66O12S (734.4275)


   

Smgdg O-18:3_10:0

Smgdg O-18:3_10:0

C37H66O12S (734.4275)


   

[1-decoxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-decoxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H67O12P (734.437)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] decanoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] decanoate

C37H67O12P (734.437)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] dodecanoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] dodecanoate

C37H67O12P (734.437)


   

[1-dodecoxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-dodecoxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C37H67O12P (734.437)


   
   

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C36H62O15 (734.4089)


   

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C36H62O15 (734.4089)


   

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H62O15 (734.4089)


   

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C36H62O15 (734.4089)


   

[6-[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[6-[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[3,4,5-trihydroxy-6-[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]oxan-2-yl]methanesulfonic acid

[3,4,5-trihydroxy-6-[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]oxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[6-[2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[6-[2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[1-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C40H63O10P (734.4159)


   

[1-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C40H63O10P (734.4159)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C36H63O13P (734.4006)


   

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C36H63O13P (734.4006)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C40H63O10P (734.4159)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C40H63O10P (734.4159)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C36H63O13P (734.4006)


   

2-(3,4-Dimethoxyphenyl)ethyl 2,3,5-tri-O-methyl-beta-(D)-apiofuranosyl(1.rar.6)-2,3,4-tri-O-methyl-alpha-(L)-rhamnopyranosyl(1.rar.3)-2,4-DI-O-methyl-beta-(D)-glucopyranoside

2-(3,4-Dimethoxyphenyl)ethyl 2,3,5-tri-O-methyl-beta-(D)-apiofuranosyl(1.rar.6)-2,3,4-tri-O-methyl-alpha-(L)-rhamnopyranosyl(1.rar.3)-2,4-DI-O-methyl-beta-(D)-glucopyranoside

C35H58O16 (734.3725)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C36H63O13P (734.4006)


   

methyl (1R,9R,12R,13Z,18R)-13-ethylidene-5-[(1R,9R,12R,13E,18S)-13-ethylidene-5-methoxy-18-methoxycarbonyl-8-methyl-8,15-diazapentacyclo[10.5.1.01,9.02,7.010,15]octadeca-2(7),3,5-trien-4-yl]-4-methoxy-8-methyl-8,15-diazapentacyclo[10.5.1.01,9.02,7.09,15]octadeca-2(7),3,5-triene-18-carboxylate

methyl (1R,9R,12R,13Z,18R)-13-ethylidene-5-[(1R,9R,12R,13E,18S)-13-ethylidene-5-methoxy-18-methoxycarbonyl-8-methyl-8,15-diazapentacyclo[10.5.1.01,9.02,7.010,15]octadeca-2(7),3,5-trien-4-yl]-4-methoxy-8-methyl-8,15-diazapentacyclo[10.5.1.01,9.02,7.09,15]octadeca-2(7),3,5-triene-18-carboxylate

C44H54N4O6 (734.4043)


   

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[(2S,3S,6S)-6-[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   
   

[(2S,3S,6S)-6-[3-dodecanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[3-dodecanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

C40H63O10P (734.4159)


   

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   
   

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C36H63O13P (734.4006)


   

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-3-decanoyloxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C36H63O13P (734.4006)


   

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-2-decanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C40H63O10P (734.4159)


   

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

[3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C40H63O10P (734.4159)


   

[(2S,3S,6S)-6-[(2S)-2,3-bis[[(E)-tetradec-9-enoyl]oxy]propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[(2S)-2,3-bis[[(E)-tetradec-9-enoyl]oxy]propoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

[(2R,3R,6R)-6-[(2S)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-undecanoyloxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2R,3R,6R)-6-[(2S)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-undecanoyloxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C37H66O12S (734.4275)


   

2-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

2-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C31H59O17P (734.349)


   
   

DGDG O-21:3;O

DGDG O-21:3;O

C36H62O15 (734.4089)


   
   
   
   
   
   

PA 14:0/20:3;O4

PA 14:0/20:3;O4

C37H67O12P (734.437)


   
   
   
   
   

PG P-20:0/11:3;O3

PG P-20:0/11:3;O3

C37H67O12P (734.437)


   

PG 18:0/13:3;O2

PG 18:0/13:3;O2

C37H67O12P (734.437)


   

PG 18:1/12:3;O3

PG 18:1/12:3;O3

C36H63O13P (734.4006)


   

PG 18:2/12:2;O3

PG 18:2/12:2;O3

C36H63O13P (734.4006)


   
   
   

PG 22:2/9:1;O2

PG 22:2/9:1;O2

C37H67O12P (734.437)


   
   
   
   

PI P-16:1/11:2;O

PI P-16:1/11:2;O

C36H63O13P (734.4006)


   

PI P-18:1/8:3;O2

PI P-18:1/8:3;O2

C35H59O14P (734.3642)


   

PI P-18:1/9:2;O

PI P-18:1/9:2;O

C36H63O13P (734.4006)


   

PI P-20:0/7:3;O

PI P-20:0/7:3;O

C36H63O13P (734.4006)


   
   
   
   
   
   

10-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C40H62O12 (734.4241)


   

12-(hydroxymethyl)-22-{[4-(5-methoxypent-3-en-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

12-(hydroxymethyl)-22-{[4-(5-methoxypent-3-en-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H54N2O10 (734.3778)


   

(7e,9r,12r,13r,16e,21s,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4e)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

(7e,9r,12r,13r,16e,21s,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4e)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H54N2O10 (734.3778)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4s,7r,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-10-hydroxy-2-(hydroxymethyl)-9,13,17-trimethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4s,7r,8s,9s,10s,12r,13r,16r,17s,18r)-16-(acetyloxy)-10-hydroxy-2-(hydroxymethyl)-9,13,17-trimethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylate

C38H54O14 (734.3513)


   

(5-hydroxy-6-{[4-hydroxy-2,5-bis(hydroxymethyl)-3-[(2-methylpropanoyl)oxy]oxolan-2-yl]oxy}-3,4-bis[(2-methylbutanoyl)oxy]oxan-2-yl)methyl decanoate

(5-hydroxy-6-{[4-hydroxy-2,5-bis(hydroxymethyl)-3-[(2-methylpropanoyl)oxy]oxolan-2-yl]oxy}-3,4-bis[(2-methylbutanoyl)oxy]oxan-2-yl)methyl decanoate

C36H62O15 (734.4089)


   

10,18,24-trihydroxy-7-[3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,20-trimethyl-19-methylidene-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,23-tetraene-2,9-dione

10,18,24-trihydroxy-7-[3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,20-trimethyl-19-methylidene-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,23-tetraene-2,9-dione

C45H54N2O7 (734.3931)


   

methyl 3',24-dihydroxy-19-methoxy-8,18'-dioxa-4,4',14',17-tetraazaspiro[heptacyclo[11.10.1.1¹,⁴.0⁷,¹¹.0¹⁷,²⁴.0¹⁸,²³.0¹¹,²⁵]pentacosane-15,16'-hexacyclo[9.9.2.0¹,¹⁷.0⁴,²².0⁵,¹⁰.0¹⁴,²¹]docosane]-5',7',9',11'(22'),18,20,22-heptaene-3'-carboxylate

methyl 3',24-dihydroxy-19-methoxy-8,18'-dioxa-4,4',14',17-tetraazaspiro[heptacyclo[11.10.1.1¹,⁴.0⁷,¹¹.0¹⁷,²⁴.0¹⁸,²³.0¹¹,²⁵]pentacosane-15,16'-hexacyclo[9.9.2.0¹,¹⁷.0⁴,²².0⁵,¹⁰.0¹⁴,²¹]docosane]-5',7',9',11'(22'),18,20,22-heptaene-3'-carboxylate

C43H50N4O7 (734.3679)


   

2-{[3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-4-yl acetate

2-{[3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-4-yl acetate

C38H54O14 (734.3513)


   

5-{[7,11-bis(acetyloxy)-1-[2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

5-{[7,11-bis(acetyloxy)-1-[2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C40H62O12 (734.4241)


   

(2e)-4-[(2-{3-hydroxy-4-[(4z,6z,12z,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-6-isopropyl-2-methoxy-5-methyloxan-4-yl)oxy]-4-oxobut-2-enoic acid

(2e)-4-[(2-{3-hydroxy-4-[(4z,6z,12z,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-6-isopropyl-2-methoxy-5-methyloxan-4-yl)oxy]-4-oxobut-2-enoic acid

C40H62O12 (734.4241)


   

(6r,7r)-1-[4-(acetyloxy)undecyl]-4,7-dihydroxy-6-{[(4e)-6-methyl-9-phenylnon-4-enoyl]oxy}-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

(6r,7r)-1-[4-(acetyloxy)undecyl]-4,7-dihydroxy-6-{[(4e)-6-methyl-9-phenylnon-4-enoyl]oxy}-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C38H54O14 (734.3513)


   

5-{[7-(acetyloxy)-1-[2-(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

5-{[7-(acetyloxy)-1-[2-(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C40H62O12 (734.4241)


   

(7e,16e)-12-(hydroxymethyl)-22-{[(3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

(7e,16e)-12-(hydroxymethyl)-22-{[(3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H54N2O10 (734.3778)


   

1-acetyl-7-({5-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 2-methylbut-2-enoate

1-acetyl-7-({5-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 2-methylbut-2-enoate

C40H62O12 (734.4241)


   

(3e,6r)-6-[(1r,2r,3as,3bs,4s,9ar,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6r)-6-[(1r,2r,3as,3bs,4s,9ar,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H54O14 (734.3513)


   

(1s,3s,7r,8s,10r,13s,17r,18s,21r,22s)-10,18,24-trihydroxy-7-[(2r,3s,4r)-3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,19,20-tetramethyl-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,19,23-pentaene-2,9-dione

(1s,3s,7r,8s,10r,13s,17r,18s,21r,22s)-10,18,24-trihydroxy-7-[(2r,3s,4r)-3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,19,20-tetramethyl-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,19,23-pentaene-2,9-dione

C45H54N2O7 (734.3931)


   

(3s)-5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7,11-bis(acetyloxy)-1-[(2s,3r,6r)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

(3s)-5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7,11-bis(acetyloxy)-1-[(2s,3r,6r)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C40H62O12 (734.4241)


   

10,18,24-trihydroxy-7-[3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,19,20-tetramethyl-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,19,23-pentaene-2,9-dione

10,18,24-trihydroxy-7-[3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,19,20-tetramethyl-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,19,23-pentaene-2,9-dione

C45H54N2O7 (734.3931)


   

4-(acetyloxy)-2-{[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(acetyloxy)methyl]-5-hydroxyoxan-3-yl octadecanoate

4-(acetyloxy)-2-{[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(acetyloxy)methyl]-5-hydroxyoxan-3-yl octadecanoate

C36H62O15 (734.4089)


   

n-[(3s,6s,9s,12r,13s,16r,21as)-6-benzyl-1,7,14-trihydroxy-3-[(4-hydroxyphenyl)methyl]-16-isopropyl-5,9,12-trimethyl-4,10,17-trioxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-l]1-oxa-4,7,10,13,16-pentaazacyclononadecan-13-yl]ethanimidic acid

n-[(3s,6s,9s,12r,13s,16r,21as)-6-benzyl-1,7,14-trihydroxy-3-[(4-hydroxyphenyl)methyl]-16-isopropyl-5,9,12-trimethyl-4,10,17-trioxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[2,1-l]1-oxa-4,7,10,13,16-pentaazacyclononadecan-13-yl]ethanimidic acid

C38H50N6O9 (734.3639)


   

5-amino-2-{[5-(n,3-dihydroxy-2-{[1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-1-hydroxy-2-(methylamino)pentylidene]amino}-n-{2-hydroxy-1-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}pentanimidic acid

5-amino-2-{[5-(n,3-dihydroxy-2-{[1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-1-hydroxy-2-(methylamino)pentylidene]amino}-n-{2-hydroxy-1-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}pentanimidic acid

C29H54N10O12 (734.3922)


   

(2r,3r,4s,5r,6r)-5-hydroxy-2-{[(2s,3s,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-{[(2r)-2-methylbutanoyl]oxy}-2-({[(2r)-2-methylbutanoyl]oxy}methyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)-4-[(2-methylpropanoyl)oxy]oxan-3-yl decanoate

(2r,3r,4s,5r,6r)-5-hydroxy-2-{[(2s,3s,4r,5r)-4-hydroxy-5-(hydroxymethyl)-3-{[(2r)-2-methylbutanoyl]oxy}-2-({[(2r)-2-methylbutanoyl]oxy}methyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)-4-[(2-methylpropanoyl)oxy]oxan-3-yl decanoate

C36H62O15 (734.4089)


   

1-[18-({4,5-dihydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-7-en-8-yl]-2-methylpropan-1-one

1-[18-({4,5-dihydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-7-en-8-yl]-2-methylpropan-1-one

C40H62O12 (734.4241)


   

(1s,3s,7r,8s,10r,13s,17r,18s,20s,21r,22s)-10,18,24-trihydroxy-7-[(2r,3s,4r)-3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,20-trimethyl-19-methylidene-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,23-tetraene-2,9-dione

(1s,3s,7r,8s,10r,13s,17r,18s,20s,21r,22s)-10,18,24-trihydroxy-7-[(2r,3s,4r)-3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-22-(1h-indol-3-ylmethyl)-11,13,20-trimethyl-19-methylidene-23-azatetracyclo[15.7.0.0¹,²¹.0³,⁸]tetracosa-5,11,15,23-tetraene-2,9-dione

C45H54N2O7 (734.3931)


   

(2r,4as,4br,6r,7r,10ar)-6-hydroxy-7-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

(2r,4as,4br,6r,7r,10ar)-6-hydroxy-7-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4s,5s,6r)-4-hydroxy-5-{[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

C39H58O13 (734.3877)


   

n-[(1e)-11-[(12z,14z)-3,9-dihydroxy-11,17-dimethoxy-4,4-dimethyl-7-oxo-6,20-dioxa-21-azabicyclo[16.2.1]henicosa-1(21),12,14,18-tetraen-5-yl]-4,10-dimethoxy-5,9-dimethyl-6-oxoundec-1-en-1-yl]-n-methylformamide

n-[(1e)-11-[(12z,14z)-3,9-dihydroxy-11,17-dimethoxy-4,4-dimethyl-7-oxo-6,20-dioxa-21-azabicyclo[16.2.1]henicosa-1(21),12,14,18-tetraen-5-yl]-4,10-dimethoxy-5,9-dimethyl-6-oxoundec-1-en-1-yl]-n-methylformamide

C39H62N2O11 (734.4353)


   

(3s)-5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7-(acetyloxy)-1-[(2r,3r,6r)-2-(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

(3s)-5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7-(acetyloxy)-1-[(2r,3r,6r)-2-(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C40H62O12 (734.4241)


   

1-[(1s,4r,5r,6s,10s,12s,13s,15s,16r,18s,21r)-18-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-7-en-8-yl]-2-methylpropan-1-one

1-[(1s,4r,5r,6s,10s,12s,13s,15s,16r,18s,21r)-18-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-7-en-8-yl]-2-methylpropan-1-one

C40H62O12 (734.4241)


   

(2e)-4-{[(2r,4s,5r,6s)-2-[(2s,3r,4s)-3-hydroxy-4-[(3s,4e,6e,9s,10r,11r,12e,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-4-methoxy-5-methyloxan-2-yl]oxy}-4-oxobut-2-enoic acid

(2e)-4-{[(2r,4s,5r,6s)-2-[(2s,3r,4s)-3-hydroxy-4-[(3s,4e,6e,9s,10r,11r,12e,14e)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-6-isopropyl-4-methoxy-5-methyloxan-2-yl]oxy}-4-oxobut-2-enoic acid

C40H62O12 (734.4241)


   

n-[(1e,4s,5r,9s,10r)-11-[(3r,5r,9r,11s,12e,14e,17s)-3,9-dihydroxy-11,17-dimethoxy-4,4-dimethyl-7-oxo-6,20-dioxa-21-azabicyclo[16.2.1]henicosa-1(21),12,14,18-tetraen-5-yl]-4,10-dimethoxy-5,9-dimethyl-6-oxoundec-1-en-1-yl]-n-methylformamide

n-[(1e,4s,5r,9s,10r)-11-[(3r,5r,9r,11s,12e,14e,17s)-3,9-dihydroxy-11,17-dimethoxy-4,4-dimethyl-7-oxo-6,20-dioxa-21-azabicyclo[16.2.1]henicosa-1(21),12,14,18-tetraen-5-yl]-4,10-dimethoxy-5,9-dimethyl-6-oxoundec-1-en-1-yl]-n-methylformamide

C39H62N2O11 (734.4353)


   

(7e,9r,12r,13r,16e,21r,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

(7e,9r,12r,13r,16e,21r,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H54N2O10 (734.3778)


   

10,25-dihydroxy-7-[3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-23-(1h-indol-3-ylmethyl)-11,13,20,21-tetramethyl-19-oxa-24-azapentacyclo[15.8.0.0¹,²².0³,⁸.0¹⁸,²⁰]pentacosa-5,11,15,24-tetraene-2,9-dione

10,25-dihydroxy-7-[3-hydroxy-4-(penta-1,3-dien-1-yl)oxolan-2-yl]-23-(1h-indol-3-ylmethyl)-11,13,20,21-tetramethyl-19-oxa-24-azapentacyclo[15.8.0.0¹,²².0³,⁸.0¹⁸,²⁰]pentacosa-5,11,15,24-tetraene-2,9-dione

C45H54N2O7 (734.3931)


   

5-{[(1r,3as,7r,8r,9as,11s,11ar)-7-(acetyloxy)-1-[(2s,6r)-2-(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

5-{[(1r,3as,7r,8r,9as,11s,11ar)-7-(acetyloxy)-1-[(2s,6r)-2-(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C40H62O12 (734.4241)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-4-yl acetate

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-4-yl acetate

C38H54O14 (734.3513)


   

(2e)-4-[(2-{3-hydroxy-4-[(4e,6e,12e,14z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-6-isopropyl-2-methoxy-5-methyloxan-4-yl)oxy]-4-oxobut-2-enoic acid

(2e)-4-[(2-{3-hydroxy-4-[(4e,6e,12e,14z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-6-isopropyl-2-methoxy-5-methyloxan-4-yl)oxy]-4-oxobut-2-enoic acid

C40H62O12 (734.4241)


   

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 16-(acetyloxy)-10-hydroxy-2-(hydroxymethyl)-9,13,17-trimethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylate

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 16-(acetyloxy)-10-hydroxy-2-(hydroxymethyl)-9,13,17-trimethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylate

C38H54O14 (734.3513)


   

5-{[(1r,3as,7r,8r,9as,11s,11ar)-7,11-bis(acetyloxy)-1-[(2r,6r)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

5-{[(1r,3as,7r,8r,9as,11s,11ar)-7,11-bis(acetyloxy)-1-[(2r,6r)-2-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C40H62O12 (734.4241)


   

(2s,4r)-2-[(1s,3ar,5ar,6s,9ar,9br,11r,11as)-11-(acetyloxy)-3a,6,9a,11a-tetramethyl-7-oxo-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-6-methylhept-5-en-1-yl acetate

(2s,4r)-2-[(1s,3ar,5ar,6s,9ar,9br,11r,11as)-11-(acetyloxy)-3a,6,9a,11a-tetramethyl-7-oxo-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-6-methylhept-5-en-1-yl acetate

C40H62O12 (734.4241)


   

(2s)-n-(1-{[(4s)-4-{[(1s)-4-amino-1-[(2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]butyl]-c-hydroxycarbonimidoyl}-4-(methylamino)butyl](hydroxy)carbamoyl}-2-hydroxyethyl)-5-(n-hydroxyformamido)-2-(methylamino)pentanimidic acid

(2s)-n-(1-{[(4s)-4-{[(1s)-4-amino-1-[(2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]butyl]-c-hydroxycarbonimidoyl}-4-(methylamino)butyl](hydroxy)carbamoyl}-2-hydroxyethyl)-5-(n-hydroxyformamido)-2-(methylamino)pentanimidic acid

C29H54N10O12 (734.3922)


   

(2r,3r,4r,5r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl acetate

(2r,3r,4r,5r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl acetate

C38H54O14 (734.3513)


   

2-{[3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl acetate

2-{[3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl acetate

C38H54O14 (734.3513)


   

(7e,9r,12r,13r,16e,21s,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

(7e,9r,12r,13r,16e,21s,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H54N2O10 (734.3778)


   

1-[4-(acetyloxy)undecyl]-4,7-dihydroxy-6-[(6-methyl-9-phenylnon-4-enoyl)oxy]-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

1-[4-(acetyloxy)undecyl]-4,7-dihydroxy-6-[(6-methyl-9-phenylnon-4-enoyl)oxy]-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C38H54O14 (734.3513)


   

4-(acetyloxy)-6-[(acetyloxy)methyl]-2-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-5-hydroxyoxan-3-yl octadecanoate

4-(acetyloxy)-6-[(acetyloxy)methyl]-2-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-5-hydroxyoxan-3-yl octadecanoate

C36H62O15 (734.4089)


   

6-hydroxy-7-{[4-hydroxy-5-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

6-hydroxy-7-{[4-hydroxy-5-({4-hydroxy-5-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

C39H58O13 (734.3877)


   

[(2r,3r,4r,5r,6r)-5-hydroxy-6-{[(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-3-[(2-methylpropanoyl)oxy]oxolan-2-yl]oxy}-3,4-bis({[(2r)-2-methylbutanoyl]oxy})oxan-2-yl]methyl decanoate

[(2r,3r,4r,5r,6r)-5-hydroxy-6-{[(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-3-[(2-methylpropanoyl)oxy]oxolan-2-yl]oxy}-3,4-bis({[(2r)-2-methylbutanoyl]oxy})oxan-2-yl]methyl decanoate

C36H62O15 (734.4089)


   

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C40H62O12 (734.4241)


   

6-(2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

6-(2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H54O14 (734.3513)


   

(1s,3s,7r,8s,10r,11e,13s,15e,17r,18s,20r,21s,22r,23s)-10,25-dihydroxy-7-[(2r,3s,4r)-3-hydroxy-4-[(1e,3e)-penta-1,3-dien-1-yl]oxolan-2-yl]-23-(1h-indol-3-ylmethyl)-11,13,20,21-tetramethyl-19-oxa-24-azapentacyclo[15.8.0.0¹,²².0³,⁸.0¹⁸,²⁰]pentacosa-5,11,15,24-tetraene-2,9-dione

(1s,3s,7r,8s,10r,11e,13s,15e,17r,18s,20r,21s,22r,23s)-10,25-dihydroxy-7-[(2r,3s,4r)-3-hydroxy-4-[(1e,3e)-penta-1,3-dien-1-yl]oxolan-2-yl]-23-(1h-indol-3-ylmethyl)-11,13,20,21-tetramethyl-19-oxa-24-azapentacyclo[15.8.0.0¹,²².0³,⁸.0¹⁸,²⁰]pentacosa-5,11,15,24-tetraene-2,9-dione

C45H54N2O7 (734.3931)


   

(3e,6s)-6-[(1r,2r,3as,3bs,4r,9ar,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6s)-6-[(1r,2r,3as,3bs,4r,9ar,9bs,11ar)-2,4-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H54O14 (734.3513)


   

(1s,3as,3br,7s,9ar,9bs,11r,11as)-1-acetyl-7-{[(2r,4s,5r,6r)-5-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-2-methylbut-2-enoate

(1s,3as,3br,7s,9ar,9bs,11r,11as)-1-acetyl-7-{[(2r,4s,5r,6r)-5-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-2-methylbut-2-enoate

C40H62O12 (734.4241)